2010
DOI: 10.1039/c001260m
|View full text |Cite
|
Sign up to set email alerts
|

Myxobacterial secondary metabolites: bioactivities and modes-of-action

Abstract: The myxobacteria, long a source of fascination due to their sophisticated, social lifestyles, are now increasingly recognized as multi-producers of promising natural products. Here we provide an overview of the bioactivities and modes-of-action of these secondary metabolites, with an emphasis on potential clinical applications. Highlights of metabolite modes-of-action: case studies 3.1 Soraphen: an inhibitor of acetyl-CoA carboxylase 3.2 Corallopyronin, myxopyronin, ripostatin, and sorangicin: inhibitors of ba… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
220
0
2

Year Published

2011
2011
2015
2015

Publication Types

Select...
5
5

Relationship

1
9

Authors

Journals

citations
Cited by 284 publications
(223 citation statements)
references
References 199 publications
(175 reference statements)
1
220
0
2
Order By: Relevance
“…Most notably, under unfavourable nutrient conditions, many myxobacteria can aggregate to dense mushroom-like cell colonies and produce fruiting bodies and spores (Shimkets, 1990;Shimkets et al, 2006). In this complex, densitydependent life style, signalling compounds have a key role (Goldman et al, 2006), and myxobacteria are well known for the production of various secondary metabolites and thus are prime targets for the search of new secondary metabolites (Gerth et al, 2003;Wenzel and Mü ller, 2007;Weissman and Mü ller, 2010). They contain the largest genomes of all prokaryotes and the genome of Sorangium cellulosum, with 413 Mbp as the largest bacterial genome sequenced to date (Schneiker et al, 2007).…”
Section: Introductionmentioning
confidence: 99%
“…Most notably, under unfavourable nutrient conditions, many myxobacteria can aggregate to dense mushroom-like cell colonies and produce fruiting bodies and spores (Shimkets, 1990;Shimkets et al, 2006). In this complex, densitydependent life style, signalling compounds have a key role (Goldman et al, 2006), and myxobacteria are well known for the production of various secondary metabolites and thus are prime targets for the search of new secondary metabolites (Gerth et al, 2003;Wenzel and Mü ller, 2007;Weissman and Mü ller, 2010). They contain the largest genomes of all prokaryotes and the genome of Sorangium cellulosum, with 413 Mbp as the largest bacterial genome sequenced to date (Schneiker et al, 2007).…”
Section: Introductionmentioning
confidence: 99%
“…Therefore myxobacteria play in the same league as actinobacteria and fungi as producers of bioactive secondary metabolites. 6 During our ongoing in-house screening for bioactive metabolites from myxo-and other gliding bacteria, especially new families, genera and even species turned out to be reliable sources for new types of secondary metabolites. [7][8][9] The genus Aggregicoccus belongs to the family Myxococcaceae, suborder Cystobacterineae and was up to date completely unexplored regarding the production of secondary metabolites.…”
mentioning
confidence: 99%
“…There is, however, a paucity of such controllable expression systems in the Gram-negative soil bacterium Myxococcus xanthus, a model prokaryotic system used to investigate molecular mechanisms involved in multicellular development (23), in coordinated cell movements (24,32,49), and in social behavior (44). M. xanthus is also used to study cellular responses to external signals such as light and their regulation at the level of signal transduction and gene expression (5)(6)(7) and is a potential source of bioactive secondary metabolites (45). Most gene function analyses in M. xanthus have relied upon tools such as transposon insertions of transcriptional reporters (25), nonpolar in-frame gene deletions (46), and constitutive overexpression of genes (29,34,47).…”
mentioning
confidence: 99%